{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:09:19Z","timestamp":1762160959189,"version":"3.40.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.euroneuro.2012.08.005","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T03:31:16Z","timestamp":1345779076000},"page":"960-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacological evaluation of SN79, a sigma (\u03c3) receptor ligand, against methamphetamine-induced neurotoxicity in vivo"],"prefix":"10.1016","volume":"23","author":[{"given":"Nidhi","family":"Kaushal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Seminerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rae R.","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2012.08.005_bib1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1476-5381.1993.tb12847.x","article-title":"Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine","volume":"108","author":"Baldwin","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib2","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-3565(25)38650-7","article-title":"Further studies on the role of hyperthermia in methamphetamine neurotoxicity","volume":"268","author":"Bowyer","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/syn.890110404","article-title":"Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography","volume":"11","author":"Brunswick","year":"1992","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2012.08.005_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.06.013","article-title":"Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs","volume":"120","author":"Callaghan","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(00)02107-7","article-title":"Time-course of methamphetamine-induced neurotoxicity in rat caudate-putamen after single-dose treatment","volume":"863","author":"Cappon","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2012.08.005_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-3565(24)37016-8","article-title":"Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration","volume":"283","author":"Fleckenstein","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)00656-8","article-title":"A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein","volume":"806","author":"Fukumura","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.2002.tb04182.x","article-title":"Comparative effect of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study","volume":"965","author":"Gough","year":"2002","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00213-004-1920-9","article-title":"Sigma receptors: biology and therapeutic potential","volume":"174","author":"Guitart","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.08.005_bib11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/npp.2011.276","article-title":"Is cognitive functioning impaired in methamphetamine users? A critical review","volume":"37","author":"Hart","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.08.005_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(95)00218-F","article-title":"Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals","volume":"677","author":"Hirata","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1208\/s12248-011-9274-9","article-title":"Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2-(3H)-one (SN79), a cocaine antagonist, in rodents","volume":"13","author":"Kaushal","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuropharm.2011.06.028","article-title":"CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice","volume":"61","author":"Kaushal","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2012.08.005_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1124\/mol.111.074120","article-title":"AC927, a sigma receptor ligands, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells","volume":"81","author":"Kaushal","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/157015911795016930","article-title":"Role of sigma receptors in methamphetamine-induced neurotoxicity","volume":"9","author":"Kaushal","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib17","unstructured":"Kaushal, N., McCurdy, C.R., Matsumoto, R.R., 2011c. SN79 Attenuates the Neurotoxic Effect of Methamphetamine: In Vivo and in Vitro Studies. Society for Neuroscience meeting 2011 Program 367.03"},{"key":"10.1016\/j.euroneuro.2012.08.005_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0736-5748(00)00022-8","article-title":"Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB\/c mice","volume":"18","author":"Kita","year":"2000","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib19","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1460-9568.2007.05741.x","article-title":"Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia","volume":"26","author":"Kiyatkin","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-8993(89)90122-4","article-title":"Effects of high-dose methamphetamine administration on serotonin uptake sites in rat brain measured using [3H]cyanoimipramine autoradiography","volume":"505","author":"Kovachich","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.brainresrev.2009.03.002","article-title":"Methamphetamine toxicity and messengers of death","volume":"60","author":"Krasnova","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib22","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","article-title":"Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine","volume":"15","author":"Kuczenski","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(01)00968-2","article-title":"Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting \u03c31 receptor prodice anti-cocaine effects in mice","volume":"419","author":"Matsumoto","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib24","first-page":"871","article-title":"Attenuation of methampehtamine-induced effects through the antagonism of sigma (\u03c3) receptors: Evidence from in vivo and in vitro studies","volume":"18","author":"Matsumoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0306-4522(88)90024-3","article-title":"Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain","volume":"25","author":"McLean","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2012.08.005_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0404.2005.00432.x","article-title":"Function of sigma1 receptors in Parkinson's disease","volume":"112","author":"Mishina","year":"2005","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuropharm.2005.04.016","article-title":"Involvement of sigma receptors in the actions of methamphetamine: receptor binding and behavioral studies","volume":"49","author":"Nguyen","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2012.08.005_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejphar.2007.06.022","article-title":"Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopmaine and serotonin transporters","volume":"572","author":"Numachi","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-8993(80)90952-X","article-title":"Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study","volume":"193","author":"Ricaurte","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib30","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2174\/138161212799436601","article-title":"Sigma-1 receptors: potential targets for the treatment of substance abuse","volume":"18","author":"Robson","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11065-007-9031-0","article-title":"Neurocognitive effects of methamphetamine: a critical review and meta-analysis","volume":"17","author":"Scott","year":"2007","journal-title":"Neuropsychological. Rev."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.1988.tb42104.x","article-title":"Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections","volume":"537","author":"Seiden","year":"1988","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib33","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2174\/138161207780858375","article-title":"Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290\/51","volume":"13","author":"Sharma","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib34","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.2174\/138161210793563365","article-title":"Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands","volume":"16","author":"van Waarde","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0031-6997(25)00047-X","article-title":"Sigma receptors: biology and function","volume":"42","author":"Walker","year":"1990","journal-title":"Pharmacological. Rev."},{"key":"10.1016\/j.euroneuro.2012.08.005_bib36","doi-asserted-by":"crossref","first-page":"7838","DOI":"10.1523\/JNEUROSCI.20-20-07838.2000","article-title":"Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity","volume":"20","author":"Xie","year":"2000","journal-title":"J. Neurosci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12002234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12002234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:16:14Z","timestamp":1744002974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X12002234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0924977X12002234"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.08.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"type":"print","value":"0924-977X"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological evaluation of SN79, a sigma (\u03c3) receptor ligand, against methamphetamine-induced neurotoxicity in vivo","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}